For citations:
Sysoeva E.P., Ponomarev R.V., Lukina K.A., Chavynchak R.B., Korotkova S.B., Zhilyaeva M.V., Nikitina E.G., Markova O.A., Gapchenko E.V., Shuster A.M., Kudlay D.A., Lukina E.A. Evaluation of the efficacy and safety of the biosimilar drug Glurazyme (imiglucerase) in patients with Gaucher disease type 1. Russian journal of hematology and transfusiology. 2020;65(1):8-23. (In Russ.) https://doi.org/10.35754/0234-5730-2020-65-1-8-23
Email this article 
